Optiver Holding’s Trueblue TBI Stock Holding History

Optiver Holding’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-296	Closed	-$1.16K	–	3078
2026 Q1	$1.16K	Sell	296 -232	-44%	-$1.03K	﹤0.01%	2027
2025 Q4	$2.4K	Hold	528	–	–	﹤0.01%	1912
2025 Q3	$3.24K	Buy	+528	New	+$3.34K	﹤0.01%	2133

Other funds holding TBI

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

IES Holdings Houston, Texas $311M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

ACM

Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Optiver Holding's TBI Position: Q2 2026 in Review

Optiver Holding sold out of Trueblue (TBI) in Q2 2026, closing a stake of 296 shares — an estimated $1.16K sold.

Optiver Holding first reported a position in TBI in Q3 2025 and held it in 3 quarters. The position peaked at $3.24K in Q3 2025. 114 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

Optiver Holding reported no remaining Trueblue position as of Q2 2026 after selling out during the quarter.
Optiver Holding sold 296 Trueblue shares in Q2 2026, an estimated $1.16K.
Optiver Holding first reported a position in Trueblue in Q3 2025 and held it in 3 quarters.
Optiver Holding's Trueblue position peaked at $3.24K in Q3 2025.
114 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.